Chemo-conization in early cervical cancer

Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S125-6. doi: 10.1016/j.ygyno.2007.07.011. Epub 2007 Aug 29.

Abstract

Objectives: The aim of the present study is to support the safety and feasibility of chemo-conization for early-stage cervical tumor in young patients wishing to preserve their fertility.

Methods: Between October 2004 and November 2006, eleven patients were scheduled for conservative treatment. Subjects were selected for this treatment on the basis of favorable cervical tumors (<3 cm) and a desire to maintain fertility. All patients underwent neoadjuvant chemotherapy followed by conization or conization alone with pelvic lymphadenectomy. Obstetrical and oncologic outcomes were evaluated.

Results and conclusions: The mean age of the eleven patients was 32 (range: 24-41), Figo Stage was IB1 in 8 cases and 3 cases were Stage IA2. Histological findings were squamous cell carcinoma in 5 patients and adenocarcinoma in 6 patients. Two patients were treated with TEP regimen every 3 weeks for three courses, while one patient had adjuvant chemotherapy with TEP. No recurrences were observed after a median follow-up of 20 months (range 7-29 months). Three pregnancies occurred during the follow-up period. Although the number is small, in selected patients this conservative approach seems to be feasible to cure early-stage cervical cancer therefore maintaining fertility.

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Chemotherapy, Adjuvant
  • Conization / methods
  • Epirubicin / administration & dosage
  • Female
  • Fertility
  • Humans
  • Ifosfamide / administration & dosage
  • Paclitaxel / administration & dosage
  • Uterine Cervical Neoplasms / drug therapy*
  • Uterine Cervical Neoplasms / surgery*

Substances

  • Epirubicin
  • Paclitaxel
  • Ifosfamide